Annual Working Capital
$215.99 M
+$234.90 M+1242.07%
December 31, 2023
Summary
- As of February 26, 2025, BCAX annual working capital is $215.99 million, with the most recent change of +$234.90 million (+1242.07%) on December 31, 2023.
- During the last 3 years, BCAX annual working capital has risen by +$234.90 million (+1242.07%).
- BCAX annual working capital is now at all-time high.
Performance
BCAX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$507.03 M
+$317.02 M+166.84%
September 30, 2024
Summary
- As of February 26, 2025, BCAX quarterly working capital is $507.03 million, with the most recent change of +$317.02 million (+166.84%) on September 30, 2024.
- Over the past year, BCAX quarterly working capital has increased by +$291.05 million (+134.75%).
- BCAX quarterly working capital is now at all-time high.
Performance
BCAX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BCAX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1242.1% | +134.8% |
| 3 y3 years | +1242.1% | +134.8% |
| 5 y5 years | +1242.1% | +134.8% |
BCAX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1242.1% | at high | +166.8% |
| 5 y | 5-year | at high | +1242.1% | at high | +166.8% |
| alltime | all time | at high | +1242.1% | at high | +166.8% |
Bicara Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $507.03 M(+166.8%) |
| Jun 2024 | - | $190.01 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $215.99 M(-1242.1%) | $215.99 M |
| Dec 2022 | -$18.91 M | - |
FAQ
- What is Bicara Therapeutics annual working capital?
- What is the all time high annual working capital for Bicara Therapeutics?
- What is Bicara Therapeutics annual working capital year-on-year change?
- What is Bicara Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly working capital year-on-year change?
What is Bicara Therapeutics annual working capital?
The current annual working capital of BCAX is $215.99 M
What is the all time high annual working capital for Bicara Therapeutics?
Bicara Therapeutics all-time high annual working capital is $215.99 M
What is Bicara Therapeutics annual working capital year-on-year change?
Over the past year, BCAX annual working capital has changed by +$234.90 M (+1242.07%)
What is Bicara Therapeutics quarterly working capital?
The current quarterly working capital of BCAX is $507.03 M
What is the all time high quarterly working capital for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly working capital is $507.03 M
What is Bicara Therapeutics quarterly working capital year-on-year change?
Over the past year, BCAX quarterly working capital has changed by +$291.05 M (+134.75%)